Table 2.
Cytology | ||||
---|---|---|---|---|
Characteristic | Abnormal (n = 52) | Normal (n = 46) | OR [95% CI] | p Value |
Anal intercourse | 0.767 | |||
No | 28 (50.9) | 27 (49.1) | Comparison Group | |
Yes | 20 (54.1) | 17 (45.9) | 1.13 [0.49, 2.62] | |
History of STD | 0.463 | |||
No | 27 (57.4) | 20 (42.6) | Comparison Group | |
Yes | 25 (50.0) | 25 (50.0) | 0.74 [0.33, 1.65] | |
Number of sex partners in the last 12 months | 0.069 | |||
0 | 4 (50.0) | 4 (50.0) | Comparison Group | |
1–3 | 24 (44.4) | 30 (55.6) | 1.95 [0.95, 4.01] | |
4 or more partners | 21 (70.0) | 9 (30.0) | 3.81 [0.90, 16.04] | |
On ARV therapy | 0.416 | |||
No | 11 (45.8) | 13 (54.2) | Comparison Group | |
Yes | 41 (55.4) | 33 (44.6) | 1.47 [0.58, 3.70] | |
CD4 count (cells/mm3) | 0.026 | |||
> 500 | 10 (33.3) | 20 (66.7) | Comparison Group | |
350–500 | 10 (50.0) | 10 (50.0) | 1.59 [1.09, 2.32] | |
200–350 | 21 (72.4) | 8 (27.6) | 2.50 [1.18, 5.26] | |
< 200 | 11 (57.9) | 8 (42.1) | 4.00 [1.28, 12.5] | |
Viral Load (copies/mL) | 0.364 | |||
< 75 | 19 (45.2) | 23 (54.8) | Comparison Group | |
75–4000 | 15 (62.5) | 9 (37.5) | 1.27 [0.80, 2.02] | |
≥ 4000 | 18 (56.3) | 14 (43.8) | 1.61 [0.64, 4.07] |
STD, sexually transmitted diseases; ARV, anti-retroviral therapy; OR, odds ratio; CI, confidence interval.